PT Actavis Indonesia (Indonesia)

Actavis Indonesia is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 1968. Actavis Indonesia is a subsidiary of Teva Pharmaceutical Industries, a global leader in generic and specialty medicines. The company focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generic and branded medications. Actavis Indonesia plays a crucial role in providing affordable and high-quality healthcare solutions to the Indonesian market. The company operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. Actavis Indonesia's product portfolio includes medications for various therapeutic areas such as cardiovascular, central nervous system, respiratory, and oncology, among others. Some of the well-known brands under Actavis include Actonel, Asacol, and Rapaflo. Globally, Teva Pharmaceutical Industries, the parent company, operates in over 60 countries, with a significant presence in North America, Europe, and Asia-Pacific. Actavis Indonesia benefits from Teva's extensive research and development capabilities, allowing it to introduce innovative and effective treatments to the Indonesian market. Actavis Indonesia collaborates with various healthcare organizations and participates in joint ventures to enhance its product offerings and expand its market reach. The company is a member of several pharmaceutical associations, contributing to the development of the industry in Indonesia. With a commitment to improving patient health and well-being, Actavis Indonesia aims to deliver high-quality pharmaceutical products while maintaining ethical business practices and sustainability. The company's mission is to be a trusted partner in healthcare, providing solutions that improve the quality of life for patients across Indonesia.